Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Stimwave LLC
Chronic pain treatment company Nevro has filed suit against rival Stimwave Tech alleging patent infringement.
While demand for spinal cord stimulation (SCS) devices used in pain management continues to expand at double-digit rates, a small but growing number of highly innovative companies that develop stimulators to specifically target peripheral nerve pain is creating excitement among pain doctors looking for better options to treat an intractable population that's seen little success with standard therapy. With millions of people worldwide suffering from low back pain, severe headaches and migraines, neck pain and other chronic pain, the demand for safe, effective, percutaneously-placed devices remains high. In this article, we'll highlight emerging companies working on PNS devices and provide insights from pain physicians on the pros and cons of these devices.
Only 10 approvals from outside the US were recorded in May in Medtech Insight's approvals tracker. Half of those were for in vitro diagnostics, including three for companion diagnostic for cancer drugs.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
- Implantable Devices
- Radiofrequency Devices
- Other Names / Subsidiaries
- Epimed International
- Freedom Neuro BV
- Neural Micro Incorporated
- StimRelieve, LLC.
- StimQ LLC
- Stimwave Medical PTY LTD
- Stimwave Neuro LP
- Stimwave Technologies Incorporated
- Stimwave Technologies LTD